SCHEMBL335946

SCHEMBL335946

Nc1nc2ccc(NC(=O)C(O)C(NC(=O)c3cc4ccc(Br)cc4o3)c3ccccc3)cc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 4/20 0.38
MMP9 P14780 4/20 0.38
MMP8 P22894 4/20 0.38
MMP13 P45452 4/20 0.38
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
MAPT P10636 4/20 0.38
TP53 P04637 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RXFP1 Q9HBX9 2/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38
NLRP3 Q96P20 1/20 0.38
POLB P06746 3/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL336155 0.83 TAS1R3 (0.45) MMP2NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL15282285 0.81 ACP1 (0.46) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL15282212 0.81 ACP1 (0.46) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL335390 0.81 ABL1 (0.44) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL336367 0.80 MAPT (0.47) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL335834 0.80 RAB9A (0.42) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL335948 0.80 ABL1 (0.45) MMP2MMP9MMP8MMP13NPC1
SCHEMBL335286 0.79 ACP1 (0.42) MMP2MMP9MMP8MMP13NPC1
SCHEMBL335576 0.79 ABL1 (0.43) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL335351 0.79 EGFR (0.50) NPC1RAB9ASMN1; SMN2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097758-B2 Isoserine derivatives for use as coagulation factor IXa inhibitors SANOFI-AVENTIS (FR) 2012-01-17 US claimed